Atara Biotherapeutics
ATRA
ATRA
112 hedge funds and large institutions have $833M invested in Atara Biotherapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 15 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
18% less capital invested
Capital invested by funds: $1.01B → $833M (-$179M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
112
Holding in Top 10
–
Calls
$2.84M
Puts
$1.25M
Top Buyers
| 1 | +$40.5M | |
| 2 | +$18.5M | |
| 3 | +$16.9M | |
| 4 |
Morgan Stanley
New York
|
+$13.5M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$13.4M |
Top Sellers
| 1 | -$42.4M | |
| 2 | -$5.48M | |
| 3 | -$5.33M | |
| 4 |
Millennium Management
New York
|
-$3.91M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.14M |